Índice glicêmico: uma abordagem crítica acerca de sua utilização na prevenção e no tratamento de fatores de risco cardiovasculares
Palavras-chave:
Índice glicêmico, Doenças cardiovasculares, Aterosclerose. Dislipidemias, CarboidratosResumo
As doenças cardiovasculares são consideradas um grande problema de saúde pública, uma vez que são a principal causa de morte no Brasil e no mundo. Essas doenças possuem etiologia multifatorial. Além da susceptibilidade genética, outros fatores, tais como idade e presença de hipertensão arterial, dislipidemias, obesidade, diabetes mellitus, inatividade física e alguns hábitos alimentares inadequados, são considerados importantes fatores de risco para o desenvolvimento de doenças cardiovasculares. O elevado consumo de carboidratos tem sido associado ao aumento da obesidade, às dislipidemias, à intolerância à glicose/diabetes mellitus e à resistência insulínica, estando, dessa forma, entre os fatores de risco das doenças cardiovasculares. Entretanto, existem controvérsias acerca da influência da qualidade do carboidrato ingerido no desenvolvimento de tais doenças, independentemente da quantidade ingerida. O índice glicêmico é um indicador da qualidade do carboidrato ingerido. Sua utilidade em condições de vida livre tem sido questionada, devido à interferência de vários fatores, os quais são difíceis de serem controlados sob tais condições. Este trabalho objetivou analisar criticamente os estudos que avaliaram o efeito do índice glicêmico dos alimentos na manifestação de doenças cardiovasculares e seus fatores de risco.
Referências
Cervato AM, Mazzilli RN, Martins IS, Marucci MFN. Dieta habitual e fatores de risco para doenças cardiovasculares. Rev Saúde Pública. 1997; 31(3): 227-35.
Lotufo PA. Mortalidade precoce por doenças do coração no Brasil. Comparação com outros países. Arq Bras Cardiol. 1998; 70(5):321-5.
Rique ABR, Soares EA, Meirelles CM. Nutrição e exercício na prevenção e controle das doenças cardiovasculares. Rev Bras Med Esporte. 2002; 8(6): 244-54.
Santos Filho RD, Martinez TLR. Fatores de risco para doença cardiovascular: velhos e novos fatores de risco, velhos problemas! Arq Bras Endocrinol Metabol. 2002; 46(3):212-4.
Murphy NF, Simpson CR, MacIntyre K, McAlister FA, Chalmers J, McMurray JJV. Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study. Heart. 2006; 92(8):1047-54.
Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, et al. Task force on the management of stable angina pectoris of the european society of cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary. The task force on the management of stable angina pectoris of the european society of cardiology. Eur Heart J. 2006; 27(11):1341-81.
Santos CRB, Portella ES, Ávila SS, Soares EA. Fatores dietéticos na prevenção e tratamento de comorbidades associadas à síndrome metabólica. Rev Nutr. 2006; 19(3):389-401.
International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome, 2006 [cited 2007 Dec 17]. Available from: <http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf>.
Popkin BM. The nutrition transition and obesity in the developing world. J Nutr. 2001; 131(3): 871s-3s.
Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, et al. AHA Guidelines for primary prevention of cardiovascular disease and stroke: 2002 update consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation. 2002; 106(3):388-91.
Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. IV Diretriz brasileira sobre dislipidemias e prevenção da aterosclerose. Arq Bras Cardiol. 2007; 88(Supl.1):2s-19s.
Roos NM, Bots ML, Katan MB. Replacement of dietary satured fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler Thromb Vasc Biol. 2001; 1(7):1233.
Frost G, Leeds A, Trew G, Margara R, Dornhorst A. Insulin sensitivity in women at risk of coronary heart disease and the effect of a low glycemic diet. Metabolism. 1998; 47(10):1245-51.
Oh K, Hu FB, Cho E, Rexrode KM, Stampfer MJ, Manson JE, et al. Carbohydrate intake, glycemic index, glycemic load, and dietary fiber in relation to risk of stroke in women. Am J Epidemiol. 2005; 161(2):161-9.
Liu S, Manson JE, Stampfer MF, Holmes MD, Hu FB, Hankinson SE, et al. Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women. Am J Clin Nutr. 2001; 73(3):560-6.
Ebbeling CB, Leidig MM, Sinclair KB, SegerShippee LG, Feldman HA, Ludwig DS. Effects of an ad libitum low-glycemic load diet on cardiovascular disease risk factors in obese young adults. Am J Clin Nutr. 2005; 81(5):976-82.
Beebe C. Diets with a low glycemic index: not ready for practice yet! Nutr Today. 1999; 34(2):82-6.
Franz MJ. In defense of the American Diabetes Association’s recomendations on the glycemic index. Nutr Today. 1999; 34(2):78-81.
Olendzki BC, Ma Y, Culver AL, Pharm BS, Ockene IS, Griffith JA, et al. Methodology for adding glycemic index and glycemic load values to 24-hour dietary recall database. Nutrition. 2006; 22(11-12):1087-95.
Jenkins DJA, Kendall CWW, Augustin LSA, Franceschi S, Hamidi M, Marchie A, et al. Glycemic index: overview of implications in health and disease. Am J Clin Nutr. 2002; 76(Suppl):266S-73S.
Leeds AR. Glycemic index and heart disease. Am J Clin Nutr. 2002; 7(1):286s-9s.
Jiménez-Cruz A, Turnbull WH, Bacardi-Gascón M, Rosales-Garay P. A high-fiber, moderate-glycemicindex, Mexican style diet improves dyslipidemia in individuals with type 2 diabetes. Nutr Res. 2004; 24(1):19-27.
Sahyoun NR, Anderson AL, Kanaya AM, KohBanerjee P, Kritchevsky SB, Rekeneire N, et al. Dietary glycemic index and load, measures of glucose metabolism, and body fat distribution in older adults. Am J Clin Nutr. 2005; 82(3):547-52.
Wolever TMS, Mehling C. Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance. Am J Clin Nutr. 2003; 77(3):612-21.
Pi-Sunyer FX. Glycemic index and disease. Am J Clin Nutr. 2002; 76(Suppl):290S-8S.
França HH. O paradoxo da doença coronariana. Arq Bras Cardiol. 2002; 79(4):419-21.
Laville M. Could glycaemic index be the basis of simple nutritional recommendations? Br J Nutr. 2004; 91(6):803-4.
Brand-Miller J, Foster-Powell K. Diets with a low glycemic index: from theory to practice. Nutr Today. 1999; 34(2):64-72.
Sartorelli DS, Cardoso MA. Associação entre carboidratos da dieta habitual e diabetes mellitus tipo 2: evidências epidemiológicas. Arq Bras Endocrinol Metabol. 2006; 50(3):415-25.
Sheard NF, Clark NG, Brand-Miller JC, Franz MJ, PiSunyer FX, Mayer-Davis E, et al. Dietary carboidrate (amount and type) in the prevention and management of diabetes. A statement by the American Diabetes Association. Diabetes Care. 2004; 27(9):2266-70.
Amano Y, Kawakubo K, Lee JS, Tang AC, Sugiyama M, Mari K. Correlation between dietary glycemic index and cardiovascular disease risk factors among Japanese women. Eur J Clin Nutr. 2004; 58(11): 1472-8.
Brand-Miller JC. Postprandial glycemia, glycemic index, and the prevention of type 2 diabetes. Am J Clin Nutr. 2004; 80(2):243-4.
Lukaczer D, Liska DJ, Lerman RH, Darland G, Schiltz B, Tripp M, et al. Effect of a low glycemic index diet with soy protein and phytosterols CVD risk factors in postmenopausal women. Nutrition. 2006; 22(2):104-13.
Erdman Jr. JW. For the AHA Nutrition Comittee. Soy protein and cardiovascular disease: a statement for healthcare professionals from the Nutrition Comittee of the AHA. Circulation. 2000; 102(20): 2555-9.
Moghadasian MH, Frolich JJ. Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: clinical and experimental evidence. Am J Med. 1999; 107(6):588-94.
Hamdy O, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, et al. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care. 2003; 26(7):2119-25.
Hermsdorff HHM, Monteiro JBR. Gordura visceral, subcutânea ou intramuscular: onde está o problema? Arq Bras Endocrinol Metabol. 2004; 48(6): 803-11.38. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes. 1998; 47(5):699-713. 39. Davidson MH, Dugan LD, Burns JH, Bova J, Story K, Drennan KB. The hypocholesterolemic effects of beta-glucan in oatmeal and oatbran. A dosecontrolled study. JAMA. 1991; 265(14):1833-9.
Ripsin CM, Keenan JM, Jacobs DR, Elmer PJ, Welch RR, van Horn L, et al. Oat products and lipid lowering. A Meta-analysis. JAMA. 1992; 267(24): 3317-25.
Mekki N, Dubois C, Charbonnier M, Cara L, Senft M, Pauli AM, et al. Effects of lowering fat and increasing dietary fiber on fasting and postprandial plasma lipids in hypercholesterolemic subjects consuming a mixed Mediterranean-Western diet. Am J Clin Nutr. 1997; 66(6):1443-51.
Kabir M, Guerre-Millo M, Laromiguere M, Siama G, Rizkalla SW. Negative regulation of leptin by chronic high-glycemic index starch diet. Metabolism. 2000; 49(6):764-9.
Pawlak DB, Kushner JA, Ludwig DS. Effects of dietary glycaemic index on adiposity, glucose homoeostasis, and plasma lipids in animals. Lancet. 2004; 364(9436):778-85.
Bassand J. Managing cardiovascular risk in patients with metabolic syndrome. Clin Cornerstone. 2006; 8(Suppl 1):S7-S14.
Pitsavos C, Panagiostakos DB, Chrysosshoou C, Papaionnou I, Papadimitriou L, Tousoulis D, et al. The adoption of mediterranean diet attenuates the development of acute coronary syndromes in people with the metabolic syndrome. Nutr J. 2003; 2(1):7.
Flint A, Moller BK, Raben A, Pedersen D, Tetens I, Holst JJ, et al. The use of glycaemic index tables to predict glycaemic index of composite breakfast meals. Br J Nutr. 2004, 91(6):979-89.
Brouns F, Bjorck I, Frayn KN, Gibbs AL, Lang V, Slama G, et al. Glycaemic index methodology. Nutr Res Rev. 2005; 18(1):145-71.
Buyken AE, Toeller M, Heitkamp G, Karamanos B, Rottiers R, Muggeo M, et al. Complications Study Group. Glycemic index in the diet of European outpatients with type 1 diabetes: relations to glycated hemoglobin and serum lipids. Am J Clin Nutr. 2001; 73(3):574-81.
Brand-Miller J, Foster-Powell K, Wolever TMS, Colagiuri S. The new glucose revolution: the authoritative guide to the glycemic index. New York: Merlowe & Company; 2002.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2023 Gisele Queiroz CARVALHO, Rita de Cássia Gonçalves ALFENAS
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
